Chosen Diagnostics is to improve health care delivery for patients by personalizing their medicine.
Chosen Diagnostics has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in October 2021.
Chosen Diagnostics's investors include National Science Foundation, National Institutes of Health, Texas HALO Fund, New Orleans BioFund, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Chosen Diagnostics is headquartered in New Orleans, United States.
Chosen Diagnostics is to improve health care delivery for patients by personalizing their medicine.
Chosen Diagnostics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chosen Diagnostics — Funding & Investors." VCBacked, October 19, 2021, https://www.vcbacked.co/company/chosen-diagnostics. Accessed August 16, 2026.
VCBacked. (2021). Chosen Diagnostics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/chosen-diagnostics
{{cite web |title=Chosen Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/chosen-diagnostics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated